Group 1 - Jyong Biotech Ltd. (MENS) has filed proposed terms to raise $18.8 million from the sale of its common stock in an IPO [1] - The filing is part of an amended F-1/A SEC registration statement [1] Group 2 - IPO Edge, led by an investing group, provides actionable information on growth stocks, including first-look IPO filings and an IPO calendar [2] - The platform also offers a database of U.S. IPOs and a guide to IPO investing, covering the entire IPO lifecycle [2]